HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ectopic High Expression of E2-EPF Ubiquitin Carrier Protein Indicates a More Unfavorable Prognosis in Brain Glioma.

AbstractAIMS:
Ubiquitination of proteins meant for elimination is a primary method of eukaryotic cellular protein degradation. The ubiquitin carrier protein E2-EPF is a key degradation enzyme that is highly expressed in many tumors. However, its expression and prognostic significance in brain glioma are still unclear. The aim of this study was to reveal how the level of E2-EPF relates to prognosis in brain glioma.
METHODS:
Thirty low-grade and 30 high-grade brain glioma samples were divided into two tissue microarrays each. Levels of E2-EPF protein were examined by immunohistochemistry and immunofluorescence. Quantitative real-time polymerase chain reaction was used to analyze the level of E2-EPF in 60 glioma and 3 normal brain tissue samples. The relationship between E2-EPF levels and prognosis was analyzed by Kaplan-Meier survival curves.
RESULTS:
E2-EPF levels were low in normal brain tissue samples but high in glioma nuclei. E2-EPF levels gradually increased as glioma grade increased (p < 0.05). Ectopic E2-EPF levels in high-grade glioma were significantly higher than in low-grade glioma (p < 0.01). The 5-year survival rate of glioma patients with high E2-EPF levels was shorter than in patients with low expression (p < 0.05). Furthermore, the 5-year survival rate of patients with ectopic E2-EPF was significantly shorter than patients with only nuclear E2-EPF (p < 0.01).
CONCLUSIONS:
These results suggest that higher E2-EPF levels, especially ectopic, are associated with higher grade glioma and shorter survival. E2-EPF levels may play a key role in predicting the prognosis for patients with brain glioma.
AuthorsXiaohui Zhang, Fangbo Zhao, Shujun Zhang, Yichun Song
JournalGenetic testing and molecular biomarkers (Genet Test Mol Biomarkers) Vol. 21 Issue 4 Pg. 242-247 (Apr 2017) ISSN: 1945-0257 [Electronic] United States
PMID28384045 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • ubiquitin carrier proteins
  • Ube2S protein, human
  • Ubiquitin-Conjugating Enzymes
Topics
  • Adolescent
  • Adult
  • Biomarkers, Tumor (metabolism)
  • Brain (pathology)
  • Brain Neoplasms (genetics)
  • Child
  • Child, Preschool
  • China
  • Female
  • Gene Expression Regulation, Neoplastic (genetics)
  • Glioma (genetics)
  • Humans
  • Infant
  • Infant, Newborn
  • Kaplan-Meier Estimate
  • Male
  • Prognosis
  • Survival Rate
  • Ubiquitin-Conjugating Enzymes (genetics, metabolism)
  • Ubiquitination (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: